Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma.

  title={Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma.},
  author={Sarah K. Knutson and Satoshi Kawano and Yukinori Minoshima and Natalie M. Warholic and K Huang and Yonghong Xiao and Tadashi Kadowaki and Mai Uesugi and Galina Kuznetsov and Namita Kumar and Tim J. Wigle and Christine R. Klaus and Christina J. Allain and Alejandra Raimondi and Nigel J. Waters and Jesse J. Smith and Margaret Porter-Scott and Richard Chesworth and Mikel P. Moyer and Robert A Copeland and Victoria M. Richon and Toshimitsu Uenaka and Roy M. Pollock and Kevin W. Kuntz and Akira Yokoi and Heike Keilhack},
  journal={Molecular cancer therapeutics},
  volume={13 4},
Mutations within the catalytic domain of the histone methyltransferase EZH2 have been identified in subsets of patients with non-Hodgkin lymphoma (NHL). These genetic alterations are hypothesized to confer an oncogenic dependency on EZH2 enzymatic activity in these cancers. We have previously reported the discovery of EPZ005678 and EPZ-6438, potent and selective S-adenosyl-methionine-competitive small molecule inhibitors of EZH2. Although both compounds are similar with respect to their… CONTINUE READING
Highly Influential
This paper has highly influenced 10 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS


Publications citing this paper.
Showing 1-10 of 100 extracted citations

Enhancer of zeste homolog 2 (EZH2) inhibitors.

Leukemia & lymphoma • 2018
View 18 Excerpts
Highly Influenced

Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets

Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale • 2017
View 6 Excerpts
Highly Influenced

ABCB1 and ABCG2 restrict the brain penetration of a panel of novel EZH2-Inhibitors.

International journal of cancer • 2015
View 3 Excerpts
Highly Influenced


Publications referenced by this paper.
Showing 1-10 of 32 references

Mutation of A677 in histone methyltransferase EZH2 in human B-cell Lymphoma Tumor Regression with EZH2 Inhibitor Mol Cancer Ther

MT McCabe, AP Graves, +3 authors Y Jiang
April 2014 853 on June • 2014

Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2.

Proceedings of the National Academy of Sciences of the United States of America • 2013
View 3 Excerpts

Similar Papers

Loading similar papers…